Drugs / Stillen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT01912066 | Sep 2012 → Mar 2014 | gastroduodenitis | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT03443804 Comparator | Jul → Nov 2014 | chronic gastritis | Daewon Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 4 | NCT02356679 Comparator | Aug 2014 → Jun 2015 | chronic gastritis | Chong Kun Dang Pharmaceutical | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2002-10-31 | Dong-A ST Co., Ltd. | Results Best Paper at United European Gastroenterology Week donga-st.com ↗
Through macroscopic, structural, and molecular biological observation, Mr. Oh confirmed Stillen®’s (DA-9601) protection of the gastric mucosa against damage from alcohol. |
All press releases naming this drug 5 releases
| Date | Issuer | Release |
|---|---|---|
| 2019-06-10 | Dong-A ST Co., Ltd. | Dong-A ST reduces the size of its ‘Stillen 2X Tablet’ for gastritis donga-st.com ↗ |
| 2008-04-22 | Dong-A ST Co., Ltd. | “Enhancing the Export Drive of Stillen® from the Philippines” donga-st.com ↗ |
| 2008-03-27 | Dong-A ST Co., Ltd. | Stillen® Sales Begin at Philippine Hospitals and Clinics donga-st.com ↗ |
| 2007-02-05 | Dong-A ST Co., Ltd. | Stillen® Dominates Chinese Gastric Market donga-st.com ↗ |
| 2002-10-31 | Dong-A ST Co., Ltd. | Best Paper at United European Gastroenterology Week donga-st.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Stillen | “Stillen tab.+Placebo of DW1401” NCT03443804 ↗ |
| Route | Oral | “tid PO” NCT03443804 ↗ |